Soleno Therapeutics
-$0.05 (-4.76%) Today
+$0.01 (+1.00%) As of 9:07 PM UTC after-hours
Why Robinhood?
You can buy or sell SLNO and other stocks, options, and ETFs commission-free!
About SLNO
Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The firm focuses on the treatment of metabolic and neurobehavioral disorder.
CEO
Anish Bhatnagar
Employees
31
Headquarters
Redwood City, California
Founded
1999
SLNO Key Statistics
Market Cap
81.94M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.12M
High Today
$1.06
Low Today
$1.00
Open Price
$1.04
Volume
842.05K
52 Week High
$4.39
52 Week Low
$1.00
SLNO Earnings
-$0.36
-$0.23
-$0.10
$0.03
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.08 per share
Actual
-$0.11 per share